Tourmaline Bio (TRML) Stock Chart & Stock Price History $18.80 +1.76 (+10.33%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$18.46 -0.34 (-1.81%) As of 03/14/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tourmaline Bio Stock Price Performance 5 Day Performance+17.35%1 Month Performance+35.94%3 Month Performance-14.93%6 Month Performance-6.56%Year-To-Date Performance-7.30%1 Year Performance-56.47% Receive TRML Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Remove Ads TRML Stock Chart for Sunday, March, 16, 2025 TRML Chart by TradingViewRemove Ads Tourmaline Bio Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/14/2025$17.04$18.80+10.33%$18.82$17.53628,156 shs$482.09 million03/13/2025$16.27$17.04+4.73%$17.18$16.34307,475 shs$436.96 million03/12/2025$16.02$16.27+1.56%$16.36$15.69269,447 shs$417.21 million03/11/2025$14.65$16.02+9.35%$16.34$14.40387,563 shs$410.80 million03/10/2025$14.38$14.65+1.88%$14.78$13.85236,148 shs$375.67 million03/07/2025$14.33$14.38+0.35%$15.66$14.20341,690 shs$368.75 million03/06/2025$12.90$14.33+11.09%$14.44$13.07228,902 shs$367.46 million03/05/2025$12.42$12.90+3.86%$12.91$12.34142,079 shs$330.80 million03/04/2025$12.33$12.42+0.73%$12.76$11.92348,522 shs$318.49 million03/03/2025$13.09$12.33-5.81%$13.28$12.04206,924 shs$316.18 million Get the Latest News and Ratings for TRML and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. 02/28/2025$12.79$13.09+2.35%$13.10$12.41142,676 shs$335.67 million02/27/2025$12.94$12.79-1.16%$13.41$12.79142,779 shs$327.97 million02/26/2025$12.55$12.94+3.11%$13.34$12.61224,594 shs$331.82 million02/25/2025$12.25$12.55+2.45%$12.72$11.95335,256 shs$321.82 million02/24/2025$12.21$12.25+0.33%$12.83$11.87294,669 shs$314.13 million02/21/2025$12.37$12.21-1.29%$12.86$12.16218,467 shs$313.06 million02/20/2025$12.60$12.37-1.83%$12.81$12.13175,742 shs$317.17 million02/19/2025$13.14$12.60-4.11%$13.09$12.54256,829 shs$323.06 million02/18/2025$13.83$13.14-4.99%$14.58$13.13313,713 shs$336.91 million02/17/2025$13.83$13.83$13.97$13.15229,174 shs$354.60 million Related Companies Dyne Therapeutics Stock Price Chart Iovance Biotherapeutics Stock Price Chart ANI Pharmaceuticals Stock Price Chart Ardelyx Stock Price Chart Adaptive Biotechnologies Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart Arvinas Stock Price Chart Arcus Biosciences Stock Price Chart Vir Biotechnology Stock Price Chart Receive TRML Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRML) was last updated on 3/16/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[Revealed] Trump’s Plan to Protect Your Savings for the Deep StateDuring Trump's first term, gold skyrocketed 52.89%. And it's already surging before his second. Last yea...Genesis Gold Group | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
